Houston AndroGel & TRTs Lawyer

AndroGel and other testosterone therapies have been reported to cause a range of severe complications, including:

• Heart attack
• Stroke
• Blood clots, including deep vein thrombosis and pulmonary embolism
• Death.

A study published in January 2014² reportedly found that TRTs could:

• Double the risk of heart attack in men younger than 65 who have a history of heart disease
• Double the risk of heart attack in men older than 65 (in absence of a history of heart disease)
• Cause risks within the first 90 days of starting a testosterone treatment.

The findings from the 2014 study spurred an FDA investigation into AndroGel and other testosterone therapies. In concluding this investigation, the FDA issued a Safety Announcement for prescription testosterone products (PTPs),³ explaining that:

• PTPs are only approved for use in men with low T caused by certain conditions, such as “disorders of the testicles, pituitary gland or brain.”
• “The benefits of these medications have not been established for the treatment of low testosterone levels due to aging.”
• The makers of PTPs are required to “add information to the labeling about a possible increased risk of heart attacks and strokes in patients taking testosterone.” They are also required to “conduct a well-designed clinical trial to more clearly address the question of whether an increased risk of heart attack or stroke exists among users of these products.”

Many of those harmed by AndroGel have filed lawsuits against AbbVie, alleging the drug maker failed to test the safety of AndroGel and failed to warn the public about the serious risks associated with its use.

In June 2014, the Judicial Panel on Multidistrict Litigation issued a Transfer Order, consolidating a number of these claims for discovery and pretrial proceedings.⁴ The U.S. District Court, Northern District of Illinois is overseeing the AndroGel multidistrict litigation (MDL No. 2545).⁵

While AndroGel claims are still pending in state and federal courts, some have already been met with stunning success:

• In July 2017, a Chicago jury hearing the second bellwether AndroGel case awarded a plaintiff $150 million in punitive damages.
• In October 2017, a Chicago jury awarded a single plaintiff $140 million in punitive damages and $140,000 in compensatory damage for his AndroGel claim.

New AndroGel claims can join the ongoing MDL or be filed as individual against AbbVie (or another TRT maker) outside of the MDL. The best decision for you will depend on the details of your claim, your needs and your goals. A lawyer at the Amaro Law Firm can provide you with more specific answers after discussing your circumstances.

When AndroGel (or other TRT) claims are successful, they can result in damages for (but not limited to):

• Past and future medical bills
• Past and future lost earnings
• Loss of consortium
• Pain and suffering.

Although we are aware that compensation can never reverse the permanent injuries or losses caused by AndroGel, we also know that financial recoveries can provide the means to get treatment, heal and rebuild lives.

If you or a loved one has been seriously or fatally injured after using AndroGel or another TRT, you can turn to an experienced dangerous drug lawyer at the Amaro Law Firm for exceptional advocacy in the pursuit of financial recovery and justice.

Call (713) 352-7975, text (281) 612-8024, or Contact our Firm for your FREE consultation and important information about your potential claim. We represent clients from across the U.S. in AndroGel & TRT claims.

Our history of extraordinary representation and success in dangerous drug claims has earned us stellar testimonials from former clients, as well as 5-star ratings on Google and Facebook.

________________________________________________________________________________

1: FDA Approval for AndroGel
2: TRT Study published in PLOS ONE
3: FDA Testosterone Safety Communication
4: JPML’s Transfer Order establishing AndroGel MDL
5: Illinois District Court’s AndroGel MDL page